Interestingly, Hippo et al. in 2004 identified an N-terminal soluble form of GPC-3 in HCC serum, which was elevated in HCC compared to cirrhotic and healthy patients [28]. This evidence concerns the gene GPC3 and hepatocellular carcinoma.